Statistical methods used via this technique in centralized monitoring.
Examining how to optimizing the time and effort of Ethics Committees to efficiently and effectively fulfill their human subjects protection remit.
Strategies for sponsors to utilize technology in reaching diverse patient populations.
Three key considerations for deploying technology to help increase diversity in trials.
Tufts Center for the Study of Drug Development and Biogen recently conducted a study to inform growing interest in improving diversity of clinical trial participation. The results of this research provide insights into increasing the community of minority investigators and study staff and presenting greater access to clinical trials among minority study volunteers.
Fully-integrated, component-based CDMS offers flexibility, customization, and efficiency.
Understanding the benefits and concerns associated with implementing datasets into clinical trial workflows.
Optimizing feasibility through increased data collection.
New investigators practicing in community-based settings bring enthusiasm and a fresh approach to clinical research, while also boosting collaboration and merging personal connection and patient-centric insights.
Data from past clinical trials has provided researchers with a good starting point to create more ECAs.
DCTs proving to solve numerous pain points for patients in clinical research.
Three key considerations for deploying technology to help increase diversity in trials.
Why constant communication and transparency are paramount to successful partnerships between pharmaceutical companies and CROs
The use of virtual trials will surge in the future and could become the de facto standard for clinical studies, says a recent Pistoia Alliance poll.
Companies that understand the regulatory environment in Europe can keep their trials on budget and on schedule.
How pharma companies can reduce the risk of failure with AI-based innovations.
How smart packaging can aid clinical trial adherence.
This paper analyses the responses from more than 800 US-based clinical trial sites to understand their decentralized clinical trial capabilities and perceptions
Sites not expected to fade away even as DCTs continue to grow past COVID-19.
The potential of next-generation platforms in transforming patient recruitment.
To overcome sponsor-related challenges and work to successfully secure more trials, there are tactical steps CROs can take.
***Live: December 9, 2020, at 11am EST| 8am PST| 4pm GMT| 5pm CET*** In this ‘D-Clinical Age’, leveraging modern technologies and new approaches and mind sets is required to accelerate the development of new treatments. This webinar will examine how data management can drive digital transformation with the right mix of technology, skills and process redesign.***On demand available after airing until Dec. 9, 2021.***
Examining how to optimizing the time and effort of Ethics Committees to efficiently and effectively fulfill their human subjects protection remit.
A look at one company’s platform approach in enabling the engineering of T-cells to identify and destroy cancer.
In an interview with Nico Saraceno at DPHARM 2024, Munther Baara, VP strategy and innovation, EDETEK touches on the features an effective AI/ML model can provide and how they benefit data management in trials.
An increase in protocol complexity is paving the way for machine learning models to optimize trial design.
For effective rollout on a global scale, sponsors must address and develop a plan around known challenges including recruitment, sit adoption, and technology integration.
Webinar Date/Time: Thu, Mar 13, 2025 11:00 AM EDT
Clinical operations professionals, burdened by lack of data standardization, turn to technology in hopes of streamlining regulatory processes for the future.